Phil. Journal of Internal Medicine (Vol.54 No.4)

Volume 54 Number 4

October - December 2016 Issue

C O N T E N T S

EDITORIAL

On Being a Doctor, Physician, and Teacher  

- Margarita T. Cayco, M.D. 

  

LEGAL PRESCRIPTION

Prescribing Dangerous Drugs and the Law (Part 3)

- Atty. Rodel V. Capule M.D. 

  

ORIGINAL PAPERS

 A Comparison Between Dialysis Versus Conservative Management as Modes of Treatment in the Management of Elderly Patients with End-Stage Renal Disease: A Systematic Review

- Kristine Mae Vega-Alava, M.D. and Vimar A. Luz, M.D. 

 

Complications of Ultrasound-Guided Percutaneous Renal Biopsy at the National Kidney and Transplant Institute: A Radiologic Perspective

Ma. Regina S. Morabe-Dy, M.D., Ferdinand L. Morabe, M.D. and Luis V. Limchiu, Jr., M.D.

The Incidence of Mycobacterium Other than Tuberculosis Isolated in Specimens Suspected of Tuberculosis in a Tertiary Hospital in the Philippines: A Retrospective Study 

-  Rosario Pinkie V. Siapno, M.D., Caroline Bernadette O. King Kay, M.D. and Julie Christie G. Visperas M.D. 

CASE REPORTS

A Rare Case of an Intracardiac Hemangioma Causing Significant Right Ventricular Outflow Tract Obstruction

- Lauro L. Abrahan, IV, M.D.,  Stephanie Martha O. Obillos, M.D., Jaime Alfonso M. Aherrera, M.D., Jezreel Taquiso, M.D., Jose Donato Magno, M.D.,

Celia Catherine Uy-Agbayani, M.D., Nelson S. Abelardo, M.D., Angelique Bea Uy, Rich Ericson King and Kathleen Rose Descallar-Mata, M.D.

An Extremely Rare Case of Primary Aorto-enteric Fistula in a Filipino Patient 

John Daniel A. Ramos, M.D., Ma. Teresa Abola, M.D., and Patrick Louie Maglaya, M.D.

Dysgenesis of the Corpus Callosum Presenting as First-onset Seizures in an Apparently Normal 32-year-old

AlvinChristian C. Borbon, MD,  Mitzi Marie Chua, M.D., and Zerlyn Leonardo, M.D.

Rituximab for Refractory Anemia and Thrombocytopenia in a Patient with Systemic Lupus Erythematosus

- Rhona L. Recto, M.D., Armin Masbang, M.D., and Charito C. Cruz-Bermudez, M.D. 

CLINICAL TRIALS

Effectiveness, Safety and Tolerability of Vildagliptin and Vildagliptin+Metformin in Real-world Setting in the Philippines—Results from the GUARD Study

- Reynaldo Rosales, M.D., Francis Domingo, M.D., and Joselito Javier, M.D.